Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Yiyao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3189-8450; OpenAlex author ID A5101491848. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 6

  1. A humanized LIF-targeting antibody synergistically enhances chemo- and immunotherapy in pancreatic cancer. Co-author DOI 10.1186/s12967-026-07723-z↗
  2. Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.18632/oncotarget.28527↗
  3. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.01.038↗
  4. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.18632/oncotarget.3171↗
  5. Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Co-author DOI 10.18632/oncotarget.1764↗
  6. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Co-author DOI 10.18632/oncotarget.2120↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingrid Herr · 5 shared papers, 2014–2024 · strength 0.34
  2. Nathalie Bauer · 4 shared papers, 2014–2024 · strength 0.31
  3. Pei Fan · 4 shared papers, 2014–2024 · strength 0.31
  4. Li Liu · 4 shared papers, 2014–2024 · strength 0.31
  5. Alexandr V. Bazhin · 3 shared papers, 2014–2024 · strength 0.26
  6. Nathalia A. Giese · 3 shared papers, 2014–2024 · strength 0.26
  7. Wei Song · 1 shared paper, 2026 · strength 0.26
  8. Fu Xu · 1 shared paper, 2026 · strength 0.26
  9. Hong Zhao · 1 shared paper, 2026 · strength 0.26
  10. Eduard Ryschich · 2 shared papers, 2015–2024 · strength 0.23
  11. Franco Fortunato · 2 shared papers, 2015–2024 · strength 0.23
  12. Thilo Hackert · 2 shared papers, 2015–2024 · strength 0.23
  13. Oliver Strobel · 2 shared papers, 2015–2024 · strength 0.23
  14. Clifford C. Nwaeburu · 3 shared papers, 2014–2016 · strength 0.12
  15. Peter Schemmer · 2 shared papers, 2014–2016 · strength 0.08
  16. Orkhan Isayev · 2 shared papers, 2014 · strength 0.07
  17. Alia Abukiwan · 1 shared paper, 2016 · strength 0.05
  18. Yefeng Yin · 1 shared paper, 2016 · strength 0.05
  19. Prince Saforo Amponsah · 1 shared paper, 2016 · strength 0.05
  20. Xi Xiao · 1 shared paper, 2016 · strength 0.05
  21. Felix Rückert · 1 shared paper, 2014 · strength 0.03
  22. Tobias Förster · 1 shared paper, 2014 · strength 0.03
  23. Michael Schaefer · 1 shared paper, 2014 · strength 0.03
  24. Jens Werner · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.